For: | Saarenheimo J, Andersen H, Eigeliene N, Jekunen AP. Current challenges in applying gene-driven therapies in clinical lung cancer practice. World J Clin Oncol 2021; 12(8): 656-663 [PMID: 34513599 DOI: 10.5306/wjco.v12.i8.656] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v12/i8/656.htm |
Number | Citing Articles |
1 |
Hang Li, Shuya Zhao, Xin Chen, Guoxing Feng, Zhiyuan Chen, Saijun Fan. MiR-145 modulates the radiosensitivity of non-small cell lung cancer cells by suppression of TMOD3. Carcinogenesis 2022; 43(3): 288 doi: 10.1093/carcin/bgab121
|
2 |
Vincenzo DE RUVO, Claudia CATACCHIO, Chiara PALLARA, Valentina LORUSSO, Marco MOSCHETTA. Role of biopsy techniques in breast cancer diagnosis: overview and update. Journal of Radiological Review 2023; 10(4) doi: 10.23736/S2723-9284.23.00259-0
|
3 |
Begoña O. Alen, Lara S. Estévez-Pérez, María Teresa Hermida-Romero, Ana Reguera-Arias, Rosario García-Campelo, Mercedes de la Torre-Bravos, Ángel Concha. Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors—Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?. Cancers 2022; 14(14): 3323 doi: 10.3390/cancers14143323
|